Australian insurance broker network AUB Group has terminated its agreement to acquire Pemba Capital Partners’ 49% stake in Coverforce Holdings, a transaction that was opposed by the company’s founder.
The deal was conditional upon, among other things, the delivery of due diligence materials by an agreed date. This deadline was not met, and the parties were unable to agree on a revised schedule, AUB...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.